• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    28.03 Down 0.77(2.67%) Jan 30, 4:04PM EST
    Add to Portfolio
    Prev Close:28.80
    Open:28.62
    Bid:21.14 x 100
    Ask:32.55 x 100
    1y Target Est:33.00
    Beta:0.65
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:27.83 - 28.99
    52wk Range:19.31 - 29.00
    Volume:232,470
    Avg Vol (3m):203,847
    Market Cap:1.05B
    P/E (ttm):49.00
    EPS (ttm):0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EBS

    Comparison

    Symbol% ChgMkt Cap
    EBSDown 2.67%1.05B

    Key Statistics

    Forward P/E (1 yr):18.56
    P/S (ttm):2.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :1.22
    Quarterly EPS Est (Dec-14) :0.67
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):2.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Emergent BioSolutions Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes specialized products for use in defense and commercial markets in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback